- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05847543
Building an AI to Infer/Predict an Estimated Stool Microbiome Profile (Poobiome)
February 5, 2025 updated by: Danone Asia Pacific Holdings Pte, Ltd.
A Study to Develop, Evaluate, and Validate a Tool to Infer/Predict an Estimated Microbiome Profile
This is a study to collect data to build, evaluate and validate (test) a tool to infer/predict an estimated microbiome (community of microorganisms such as bacteria, fungi and viruses that exists in a particular environment) profile.
The study will take place at several hospitals/clinics across Singapore, Malaysia, and Thailand.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
440
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Healthy term children aged 0 to 18 months old
Description
Inclusion Criteria:
- Children aged from 0 to 18 months old
- Parent(s) should have access to the internet and a smartphone or tablet to upload stool data and complete the study questionnaires in the OneBiome web-platform.
- Parent(s) should be able to comprehend the content of the study and to complete the study procedures in English.
- Written consent from parent.
Exclusion Criteria:
- Parent(s) incapable of completing the study questionnaires and uploading of the stool data using smart phone or tablet with internet.
- Children born before gestational age 37 weeks.
- Any other family member is enrolled in the study
- Incapability of parents of children to comply with study protocol or Investigator's uncertainty about the willingness or ability of the parents of children to comply with the protocol requirements.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Non-weaned Children
Children who have not started weaning food
|
Stool diaper data and sample collection
|
|
Weaned Children (Non-Caucasian)
Non-Caucasian children who have started weaning food
|
Stool diaper data and sample collection
|
|
Weaned Children (Caucasian)
Caucasian children who have started weaning food
|
Stool diaper data and sample collection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To collect stool data and stool samples for full microbiome analysis. To collect stool images, stool data and stool samples for full microbiome analysis
Time Frame: 7 days
|
To collect stool data and stool samples for full microbiome analysis. To collect stool images, stool data and stool samples for full microbiome analysis |
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess the microbiome composition in the stool sample of the subject
Time Frame: 7 days
|
To assess the microbiome composition in the stool sample of the subject
|
7 days
|
|
To assess the dietary pattern based on Food Frequency Questionnaire (FFQ)
Time Frame: 7 days
|
To determine/assess the eating/dietary pattern of the participants based on the Food Frequency Questionnaire (FFQ) data and reflect insights in the OneBiome report
|
7 days
|
|
To explore the association between microbiome composition and known factors that influence the microbiome in early life
Time Frame: 7 days
|
To explore the association between microbiome composition and known factors that influence the microbiome in early life including mode of delivery, antibiotic prophylaxis, infant feeding patterns and diet
|
7 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The accuracy level of the stool AI in predicting the stool consistency using BITSS versus the scores provided by parents
Time Frame: 7 days
|
The accuracy level of the stool AI in predicting the stool consistency using BITSS 4-point scale versus the scores provided by parents on the same 4-point scale
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 21, 2023
Primary Completion (Actual)
September 28, 2024
Study Completion (Actual)
December 22, 2024
Study Registration Dates
First Submitted
April 27, 2023
First Submitted That Met QC Criteria
April 27, 2023
First Posted (Actual)
May 6, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 5, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EBB19GC16961-A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Stool diaper data and sample collection
-
GlaxoSmithKlineCompletedInfections, RotavirusBulgaria, Latvia
-
GlaxoSmithKlineCompletedRotavirus GastroenteritisGreece
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid LeukemiaUnited States
-
Saint-Joseph UniversityUniversité Paris CitéCompletedSARS-CoV2 Infection, COVID-19, Gut Microbiota, Mucosal Response, ChildrenLebanon
-
Benjamin GesundheitShaare Zedek Medical CenterRecruitingAutistic DisorderIsrael
-
University of FloridaAmerican Cancer Society, Inc.CompletedHematopoietic Stem Cell Transplantation | Graft vs Host Disease | Graft Versus Host Disease | Peripheral Blood Stem Cell TransplantationUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Leukemia | Chemotherapy-Induced Gut Barrier DamageUnited States
-
MaaT PharmaRecruitingSteroid Refractory GVHD | Intestinal GVHDFrance
-
The Netherlands Cancer InstituteMaastricht University Medical Center; Academisch Medisch Centrum - Universiteit...Completed
-
PfizerTerminatedUlcerative ColitisSwitzerland